ChemoCentryx (CCXI)

[Whalatane]

tiguy They are at least 2 yrs away from having an FDA approved drug
( unless they get Fast Tracked )

They have to get thru a far larger P 3 trial which will be a big cash burn .
Next data up is the CLASSIC trial , due to read out some time in June .
The CLASSIC trial is to provide more clarity around potential safety issues if CCX168 was prescribed with full SOC ( Standard of Care ) .

IMHO this is now more of a long term hold rather then "trade around an event ". The next really big event will be P3 data in 2017.
JMO
Kiwi